The global Interventional Cardiology Devices market was valued at US$ 8827.3 million in 2022 and is projected to reach US$ 11930 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Interventional Cardiology Devices market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Interventional Cardiology Devices market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Interventional Cardiology Devices market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems. These procedures use flexible tubes and catheters thin to get way inside blood vessels to perform diagnostic test or to repair heart structures or other damaged vessels, often evading the need to have a surgical operation. Several devices used in these procedures include stent, PTCA balloon and catheters among several others. The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.
This report aims to provide a comprehensive presentation of the global market for Interventional Cardiology Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Cardiology Devices. This report contains market size and forecasts of Interventional Cardiology Devices in global, including the following market information:
- Global Interventional Cardiology Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
Growth in geriatric population is expected to boost the market growth in the near future. Moreover increasing coronary artery disease is presumed to further propel the industry growth over the next eight year period Rise in demand for minimal procedures related with invasive angioplasty. Research and development across the world for technological advancement in order to achieve competitive advantage is estimated to further fuel the market demand over the forecast period. Development and innovation in interventional cardiology has resulted in increased efficiency thus is presumed to be a major factor to fuel the market demand over the next seven years period.
We surveyed the Interventional Cardiology Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interventional Cardiology Devices Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Interventional Cardiology Devices Market Segment Percentages, by Type, 2022 (%)
- Angioplasty Balloons
- Angioplasty Stents
- Catheters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
Global Interventional Cardiology Devices Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Interventional Cardiology Devices Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Ambulatory Surgical Centers
Global Interventional Cardiology Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Interventional Cardiology Devices Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Interventional Cardiology Devices revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Interventional Cardiology Devices revenues share in global market, 2022 (%)
key players include:
- Abbott
- Acrostak
- B. Braun Melsungen
- Biosensors International
- Boston Scientific Corporation
- Cordis Corporation
- Edwards Lifesciences Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Interventional Cardiology Devices, market overview.
Chapter 2: Global Interventional Cardiology Devices market size in revenue.
Chapter 3: Detailed analysis of Interventional Cardiology Devices company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Interventional Cardiology Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
